Comparison of parameters in patients with active and inactive TAK
| Parameters | Inactive TAK (n=45) | Active TAK (n=43) | p Value |
| Age (years) | 39.54±14.75 | 37.90±15.68 | 0.227 |
| Gender (female/male) | 41/4 | 37/6 | 0.454 |
| Disease duration (months) | 15.59±6.86 | 13.94±7.43 | 0.853 |
| WBC (109/L) | 6.61±2.04 | 8.74±3.65 | 0.001 |
| LY (109/L) | 1.77±0.62 | 1.87±0.81 | 0.526 |
| NE (109/L) | 4.33±1.81 | 5.86±2.34 | 0.001 |
| PLT (109/L) | 224.16±64.14 | 266.34±91.68 | 0.004 |
| ALT (U/L) | 19.49±16.06 | 17.62±9.46 | 0.622 |
| BUN (mmol/L) | 5.69±3.96 | 5.26±2.21 | 0.498 |
| Cr (μmol/L) | 71.10±21.12 | 81.60±14.75 | 0.563 |
| IgA (g/L) | 1.82±0.95 | 2.57±1.30 | 0.007 |
| IgG (g/L) | 9.50±2.27 | 11.58±4.57 | 0.011 |
| IgM (g/L) | 1.33±0.76 | 1.38±0.85 | 0.812 |
| C3 (g/L) | 0.97±0.15 | 1.21±0.20 | 0.000 |
| C4 (g/L) | 0.59±0.29 | 0.71±0.32 | 0.079 |
| ESR (mm/hour) | 8.39 (1.00–19.00) | 33.81 (4.00–92.00) | 0.000 |
| hs-CRP (mg/L) | 1.85 (0.08–32.83) | 20.04 (0.49–38.62) | 0.000 |
ALT, alanine aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; C3, complement 3; C4, complement 4; ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; LY, lymphocyte; NE, neutrophil; n, number of patients; PLT, platelet; TAK, Takayasu’s arteritis; WBC, white blood cell.